Document is current
Any future updates will be listed below
-
Authors
Pawlowski, Colin
Puranik, Arjun
Bandi, Hari
Venkatakrishnan, A. J.
Agarwal, Vineet
Kennedy, Richard
O’Horo, John C.
Gores, Gregory J.
Williams, Amy W.
Halamka, John
Badley, Andrew D.
Soundararajan, Venky
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI110173)
amfAR, The Foundation for AIDS Research (109593-62-RGRL)
National Institute of Allergy and Infectious Diseases (AI120698)
- License Information
-
More Information
Article History
Received: 29 July 2020
Accepted: 5 February 2021
First Online: 26 February 2021
Competing interests
: One or more of the investigators associated with this project and Mayo Clinic have a Financial Conflict of Interest in technology used in the research and that the investigator(s) and Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies. ADB is a consultant for Abbvie, is on scientific advisory boards for Nference and Zentalis, and is founder and President of Splissen therapeutics. The authors from nference are employees of nference and have financial interests in the success of nference. A provisional patent application filed covers some of the findings from this study with CP, AP and VS are named as inventors, with nference as the assignee for this patent application.
